4-(trifluoromethyl)benzene-1-sulfonyl chloride

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   3,5-dimethoxyaniline. Contact us for more information.

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   3,5-dimethylbenzoyl chloride. Contact us for more information.

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   4-(1-methyl-5-(bis(2-hydroxyethyl)amino)-1h-benzimidazole-2-yl)butanoic. It belongs to apis & intermediates products category. Application: bendamustine intermediate. Contact us for more...

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   4-(4,6-dichloropyrimidin-2-yl)morpholine. It belongs to pyrimidine derivatives products category. Contact us for more information.

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   4-(aminomethyl)-1-(2-phenethyl)piperidine-4-ol. It belongs to apis & intermediates products category. Application: fenspiride intermediate. Contact us for more information.

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   4-(methoxycarbonyl)phenylborenic acid. It belongs to boric acid derivatives products category. Contact us for more information.

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   4-[(6-chloropyridin-3-yl)carbonyl]morpholine. Contact us for more information.

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals which includes   4-amino-2-chloropyrimidine. It belongs to pyrimidine derivatives products category. Contact us for more information.

Palbociclib is a Kinase Inhibitor. The mechanism of action of palbociclib is as a Kinase Inhibitor, and Cytochrome P450 3A Inhibitor.

a cyclin-dependent kinase (CDK) inhibitor that targets cyclin D1/CDK4 and cyclin D3/CDK6 at nanomolar concentrations. It inhibits retinoblastoma protein phosphorylation, which prevents CDK-mediated G1-S phase transition, arresting the cell cycle in the G1 phase, suppressing DNA synthesis, and inhibiti...

Cabozantinib was approved in November 2012 for the treatment of patients with progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC). Cabozantinib was granted orphan drug status by the FDA to facilitate development of newtreatment options for patients with MTC. It is a me...

Iguratimod is a disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Preclinical in vivo studies indicated that iguratimod was effective in an established adjuvant-induced arthritis model (ED40=3.6 mg/kg) in rats and also efficacious in a type II collagen-induced ar...

Tianjin pharmacn medical technology co ltd offers Apis, pharmaceutical intermediates and fine chemicals. Contact us for more information.

Tianjin pharmacn medical technology co ltd offers apis, pharmaceutical intermediates and fine chemicals. Contact us for more information.